Filings/XBIO/IR

XENETIC BIOSCIENCES, INC. IR

press release

PDF: Xenetic Biosciences Reports Second Quarter 2026 Financial Results and Highlights Strengthened Scientific Foundation Supporting Continued Advancement of Proprietary DNase Platform

Source document

Issuer site
Loading document…
PDF: Xenetic Biosciences Reports Second Quarter 2026 Financial Results and Highlights Strengthened Scientific Foundation Supporting Continued Advancement of Proprietary DNase Platform — XENETIC BIOSCIENCES, INC.